NCT02057380 2024-11-20A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialAstellas Pharma IncPhase 2 Completed13 enrolled
NCT00139620 2018-02-08A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic FunctionAstellas Pharma IncPhase 1 Completed39 enrolled